C12N 2740/13063
By chemical treatment
Official title: by chemical treatment
C12N2740/13063 (By chemical treatment) appears on 9 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 16
- Assignees
- 10
- Inventors
- 25
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 3 |
| 2023 | 0 | 0 |
| 2024 | 2 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Alternate detergents for viral inactivation9 Jun 2026US 12,649,907 B2Amgen Inc.
- Viral inactivation methods for continuous manufacturing of antibodies22 Oct 2024US 12,123,028 B2Bayer HealthCare LLC
- Viral clearance by low pH hold3 Sep 2024US 12,077,782 B2Regeneron Pharmaceuticals, Inc.
- Methods and compositions for inactivating enveloped viruses7 Jul 2020US 10,702,603 B2Biogen MA Inc.
- Methods and compositions for inactivating enveloped viruses29 Jan 2019US 10,188,732 B2Biogen MA Inc.
- Viral clearance by low ph hold21 Nov 2024US 2024/0384243 A1Regeneron Pharmaceuticals, Inc.
- Alternate detergents for viral inactivation7 Apr 2022US 2022/0106573 A1Amgen Inc.
- Virus Filtration of Liquid Factor VII Compositions3 Mar 2022US 2022/0064605 A1Novo Nordisk Healthcare AG
- Viral Inactivation Methods for Continuous Manufacturing of Antibodies6 Jan 2022US 2022/0002679 A1Bayer HealthCare LLC
- Viral clearance by low ph hold11 Nov 2021US 2021/0348131 A1Regeneron Pharmaceuticals, Inc.
Most cited
By later US patents
- Methods and compositions for inactivating enveloped viruses11US 10,188,732 B2Biogen MA Inc. · 2019
- Preparation of native oncornavirus envelope subunits and vaccines therefrom11US 4,406,885 AResearch Corporation · 1983
- Methods and compositions for inactivating enveloped viruses9US 10,702,603 B2Biogen MA Inc. · 2020
- Arginine inactivation of viruses9US 8,980,610 B2Biogen Idec MA Inc. · 2015
- Method of treating papilloma virus infection using hypericin8US 5,506,271 ANew York University · 1996